Alzamend NeuroALZN
13F holders, Q2 2024 (June 30)14holders +1
5new positions
4sold out
1famous investor
$0.40avg. 13F price*
At the end of Q2 2024, 14 institutions reported holding Alzamend Neuro Inc. (ALZN) in their 13F filings, up 1 from Q1 2024. 5 opened new positions and 4 sold out. The largest holders were Truist Financial Corp. ($61K), Vanguard Group Inc. ($31K) and Geode Capital Management, LLC ($21K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Alzamend Neuro Inc.
- CUSIP
- 02262M407
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $5K |
| Exits | 4 | $26K |
All 13F filers, Q1 2024 → Q2 2024: 19,548 shares bought and 26,754 shares sold, net −7,206 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Truist Financial Corp. | 0.00% | Add +0.4% | 154,993 | $61K |
| Vanguard Group Inc. | 0.00% | No change | 78,545 | $31K |
| Geode Capital Management, LLC | 0.00% | No change | 52,397 | $21K |
| BlackRock Inc. | 0.00% | No change | 39,740 | $16K |
| Renaissance Technologies | 0.00% | Add +42.8% | 19,690 | $8K |
| RFG Advisory, LLC | 0.00% | No change | 16,666 | $7K |
| CoreCap Advisors, LLC | 0.00% | New | 7,084 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +9.1% | 5,178 | $2K |
| UBS Group AG | 0.00% | New | 5,132 | $2K |
| Activest Wealth Management | 0.00% | New | 200 | $79 |
| Bank of America Corp. | 0.00% | New | 95 | $38 |
| Osaic Holdings, Inc. | 0.00% | No change | 66 | $26 |
| City State Bank | 0.00% | New | 40 | $16 |
| Morgan Stanley | 0.00% | No change | 33 | $13 |
"% of holder's portfolio" is ALZN's weight in each manager's 13F, not the share of Alzamend Neuro Inc. the manager owns.